Story thread · 2 reports / 2 sources

Neurocrine slips as safety issues linked to Vykat XR resurface

seekingalpha.com · 9h · first report

The coverage

  1. Four questions on new safety warnings for Neurocrine’s Vykat XR

    endpts.com · 1h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.